Artiva Biotherapeutics, Inc.

NasdaqGM:ARTV Stock Report

Market Cap: US$259.2m

Artiva Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ARTV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jul 24BuyUS$4,999,992venBio LLCCompany416,666US$12.00
22 Jul 24BuyUS$24,999,984GC Cell CorporationCompany2,083,332US$12.00
22 Jul 24BuyUS$99,999,996RA Capital Management, L.P.Company8,333,333US$12.00
22 Jul 24BuyUS$9,999,9965AM Venture Management, LLCCompany833,333US$12.00
22 Jul 24BuyUS$24,999,984GC Cell CorporationCompany2,083,332US$12.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARTV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders62,6980.247%
Public Companies4,567,41218%
Institutions5,453,85421.5%
VC/PE Firms15,336,14660.3%

Dilution of Shares: ARTV only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 103.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
40.6%
RA Capital Management, L.P.
9,853,302US$105.1m0%1.22%
18.8%
GC Cell Corporation
4,567,412US$48.7m0%no data
9.69%
5AM Venture Management, LLC
2,353,304US$25.1m0%5.12%
6.63%
VR Adviser, LLC
1,609,569US$17.2m0%0.82%
6.26%
venBio LLC
1,519,971US$16.2m0%9.07%
3.77%
Capital Research and Management Company
915,386US$9.8m0%no data
3.46%
The Vanguard Group, Inc.
841,005US$9.0m0%no data
3.45%
BlackRock, Inc.
837,613US$8.9m0%no data
2.14%
Franklin Resources, Inc.
520,301US$5.6m0%no data
1.27%
Geode Capital Management, LLC
308,930US$3.3m0%no data
1.2%
Samsara BioCapital LLC
291,666US$3.1m0%0.39%
1.17%
Woodline Partners LP
283,124US$3.0m0%0.02%
0.8%
Wellington Management Group LLP
194,108US$2.1m0%no data
0.61%
RTW Investments, LP
148,844US$1.6m0%0.02%
0.6%
Logos Global Management, L.P.
145,089US$1.5m0%0.18%
0.46%
Northern Trust Global Investments
112,777US$1.2m0%no data
0.43%
Citadel Advisors LLC
103,635US$1.1m0%no data
0.43%
Cormorant Asset Management, LP
103,633US$1.1m0%0.06%
0.41%
Alyeska Investment Group, L.P.
100,000US$1.1m0%no data
0.36%
State Street Global Advisors, Inc.
86,559US$923.6k0%no data
0.28%
Farringdon Capital Management
68,320US$729.0k0%0.52%
0.18%
Acuta Capital Partners, LLC
44,000US$469.5k0%0.39%
0.17%
EcoR1 Capital, LLC
41,453US$442.3k0%0.01%
0.17%
Charles Schwab Investment Management, Inc.
40,293US$429.9k0%no data
0.16%
Peter Flynn
39,899US$425.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 09:36
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Artiva Biotherapeutics, Inc. is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joshua SchimmerCantor Fitzgerald & Co.
Edward WhiteH.C. Wainwright & Co.
Dingding ShiJefferies LLC